Bleeding risk in patients treated with dabigatran or vitamin K antagonist for atrial fibrillation: A meta analysis of adjusted analysis in routine practice settings

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2016-03, Vol.206, p.89-92
Main Authors: Darwiche, Walid, Bejan-Angoulvant, Theodora, Dievart, François, Babuty, Dominique, Angoulvant, Denis, Fauchier, Laurent
Format: Article
Language:English
Subjects:
Antithrombins - administration & dosage
Antithrombins - adverse effects
Atrial fibrillation
Atrial Fibrillation - drug therapy
Atrial Fibrillation - physiopathology
Bleeding
Cardiovascular
Dabigatran
Dabigatran - administration & dosage
Dabigatran - adverse effects
Hemorrhage - chemically induced
Hemorrhage - epidemiology
Humanities and Social Sciences
Humans
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Vitamin K - antagonists & inhibitors
Warfarin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2016.01.065